Company Overview and News

 
BPCL, HPCL, IOC shares tank up to 7% on surging oil price

5h thehindubusinessline
Shares of BPCL, HPCL and IOC reeled under selling pressure today, tumbling up to 7 per cent on worries over rise in global oil prices, which impact their margins.
Upvote Downvote

 
IOC, HPCL, BPCL hit 52-week low after Brent crude crosses $74/bbl

8h moneycontrol
Oil retailers share prices hit fresh 52-week low on Thursday after Brent crude oil futures crossed the USD 74 a barrel, the highest level since late 2014.
Upvote Downvote

 
[Press] Saudi Aramco to Build $44 Billion 'Mega Refinery' in India

2018-04-18 oilvoice
Saudi Aramco has this week agreed to develop a $44 billion ‘mega refinery' on India's west coast in collaboration with three Indian state-owned oil companies. The collaboration takes the form of a Memorandum of Understanding (MoU) with Ratnagiri Refinery and Petrochemicals Ltd (RRPCL), a consortium of Indian oil companies which includes The Indian Oil Corporation (IOC), Bharat Petroleum Corporation Ltd.
Upvote Downvote

 
Market Update: CNX IT remains weak as Infosys falls 3%; Tata Motors top loser, falls 5%, Idea at 52-week low

2018-04-16 moneycontrol
The Indian equity market was trading on a negative note on Monday afternoon with the Nifty shedding 12 points and was trading just below the 10,500 mark at 10,468 while the Sensex was down 71 points or 0.21 percent.
Upvote Downvote

 
Aramco picks up 50% stake in $44b refinery

2018-04-12 freepressjournal.in
New Delhi : Saudi Aramco, the world’s largest oil producer, on Wednesday signed an agreement to pick up a 50 per cent stake in a planned $44-billion (Rs 3 lakh crore) refinery-cum-petrochemical project in Ratnagiri, Maharashtra, a move that will give it an assured customer for additional 30 million tonnes of its crude oil.
Upvote Downvote

 
OMCs’ scrips plunge on price cut buzz

2018-04-12 freepressjournal.in
Mumbai: Shares of oil marketing firms plunged on Wednesday, as reports claimed the government had asked fuel retailers to absorb a hike of up to Re 1 per litre in fuel prices. Despite swift denials by Indian Oil Corp, Bharat Petroleum Corp and Hindustan Petroleum Corp, the shares of these companies fell up to around 7 per cent. Hindustan Petroleum Corporation scrip plunged 7.57 per cent, Bharat Petroleum Corporation 7.
Upvote Downvote

 
Closing Bell: Nifty rises for 6th straight day, Sensex up 161 pts ahead of macro data

2018-04-12 moneycontrol
3:30 pm Market Closing: Benchmark indices ended higher for the sixth consecutive session, with the Sensex rising 160.69 points to 34,101.13 and the Nifty gaining 41.50 points at 10,458.70 ahead of macro data due later in the day and Infosys earnings tomorrow.
Upvote Downvote

 
HPCL, BPCL, IOC fall up to 3% on further spike in crude oil prices

2018-04-12 moneycontrol
Oil retailers extended previous day's losses, falling up to 3 percent in early trade on Thursday after further spike in crude oil prices yesterday on tensions in Middle East. In previous session, these stocks plunged around 7 percent each.
Upvote Downvote

 
India laments US$70 crude as Saudi Arabia eyes plant

2018-04-12 thestar.com.my
Better terms: A driver reads a newspaper as he sits on a spare tire attached to a parked oil tanker in Mumbai. India is seeking more favourable terms from oil producers in the Middle East. — Reuters
Upvote Downvote

 
Saudi Aramco signs $44 bn deal for Indian refinery complex

2018-04-11 yahoo
New Delhi (India) (AFP) - Saudi Aramco, the world's biggest oil company, on Wednesday announced a $44-billion deal to build a giant refinery complex in India with three Indian firms.
Upvote Downvote

 
India, Aramco to partner on $44-b refinery-petchem project

2018-04-11 thehindubusinessline
Saudi Aramco on Wednesday signed an initial deal with a consortium of Indian refiners to build a $44-billion refinery and petrochemical project on India’s west coast, as the kingdom moves to secure buyers for its crude in a market awash with oil.
Upvote Downvote

 
India, Aramco To Partner On $44B Refinery-Petchem Project

2018-04-11 rigzone
NEW DELHI, April 11 (Reuters) - Saudi Aramco on Wednesday signed an initial deal with a consortium of Indian refiners to build a $44 billion refinery and petrochemical project on India's west coast, as the kingdom moves to secure buyers for its crude in a market awash with oil.
Upvote Downvote

 
News Live: US-Russia relationship #39;worse now#39; than during Cold War, says Trump

2018-04-11 moneycontrol
Our relationship with Russia is worse now than it has ever been, and that includes the Cold War. There is no reason for this. Russia needs us to help with their economy, something that would be very easy to do, and we need all nations to work together. Stop the arms race?:US Pres pic.twitter.com/WtxfwMRHvT
Upvote Downvote

 
News Live: Walmart favoured over Amazon to buy Flipkart, says report

2018-04-11 moneycontrol
Walmart looks likely to take the next round in the battle for India’s retail market over rival Amazon.com, reports Bloomberg. Flipkart Online Services Pvt is leaning toward selling a controlling stake to Walmart, rather than Amazon, because of the greater certainty in such a deal, sources said. Both US companies are bidding for a controlling stake in Flipkart at a valuation of about $20 billion, sources added.
Upvote Downvote

 
News Live: All 6 home IPL matches of Super Kings shifted out of Chennai

2018-04-11 moneycontrol
Cyient said it entered into a joint venture with Israel-based BluBird Aero Systems to offer field-proven UAV systems to Indian defence, paramilitary, security, and police forces.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...